Bala Gür Dedeoğlu

628 total citations
33 papers, 494 citations indexed

About

Bala Gür Dedeoğlu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Bala Gür Dedeoğlu has authored 33 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Bala Gür Dedeoğlu's work include MicroRNA in disease regulation (11 papers), RNA Research and Splicing (7 papers) and Molecular Biology Techniques and Applications (5 papers). Bala Gür Dedeoğlu is often cited by papers focused on MicroRNA in disease regulation (11 papers), RNA Research and Splicing (7 papers) and Molecular Biology Techniques and Applications (5 papers). Bala Gür Dedeoğlu collaborates with scholars based in Türkiye, United States and United Kingdom. Bala Gür Dedeoğlu's co-authors include Işık G. Yuluğ, Hakan Gürdal, Betül Bozkurt, Özlen Konu, Hakime Öztürk, Selda Seçkın, Ferit Avcu, Yusuf Baran, Ali Uğur Ural and Ufuk Gündüz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.

In The Last Decade

Bala Gür Dedeoğlu

32 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bala Gür Dedeoğlu Türkiye 15 347 195 122 36 34 33 494
Kazutsune Yamagata Japan 12 474 1.4× 112 0.6× 81 0.7× 48 1.3× 30 0.9× 21 538
Anderson T. Wang United Kingdom 11 778 2.2× 191 1.0× 229 1.9× 101 2.8× 31 0.9× 16 911
Chandrahas Koumar Ratnacaram India 8 338 1.0× 83 0.4× 123 1.0× 42 1.2× 20 0.6× 10 498
Tovah A. Day United States 12 392 1.1× 122 0.6× 203 1.7× 27 0.8× 14 0.4× 18 477
Senthilkumar Cinghu United States 12 706 2.0× 156 0.8× 136 1.1× 54 1.5× 15 0.4× 16 842
Baofeng Jin China 13 292 0.8× 86 0.4× 83 0.7× 27 0.8× 19 0.6× 19 406
Wytse Bruinsma Netherlands 9 515 1.5× 80 0.4× 212 1.7× 24 0.7× 25 0.7× 9 640
Stéphanie Bianco Canada 12 330 1.0× 103 0.5× 105 0.9× 182 5.1× 34 1.0× 17 524
Miriam Teeuwssen Netherlands 7 396 1.1× 160 0.8× 246 2.0× 107 3.0× 19 0.6× 8 637
Eun Jeong Kwon South Korea 7 371 1.1× 121 0.6× 115 0.9× 30 0.8× 13 0.4× 9 538

Countries citing papers authored by Bala Gür Dedeoğlu

Since Specialization
Citations

This map shows the geographic impact of Bala Gür Dedeoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bala Gür Dedeoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bala Gür Dedeoğlu more than expected).

Fields of papers citing papers by Bala Gür Dedeoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bala Gür Dedeoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bala Gür Dedeoğlu. The network helps show where Bala Gür Dedeoğlu may publish in the future.

Co-authorship network of co-authors of Bala Gür Dedeoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Bala Gür Dedeoğlu. A scholar is included among the top collaborators of Bala Gür Dedeoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bala Gür Dedeoğlu. Bala Gür Dedeoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dedeoğlu, Bala Gür, et al.. (2025). DUSP1 protein's impact on breast cancer: Anticancer response and sensitivity to cisplatin. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1868(3). 195103–195103. 1 indexed citations
2.
Dedeoğlu, Bala Gür, et al.. (2025). Upregulation of miR-99b-5p Modulates ESR1 Expression as an Adaptive Mechanism to Circumvent Drug Response via Facilitating ER/HER2 Crosstalk. Balkan Medical Journal. 42(2). 150–156. 3 indexed citations
3.
Dedeoğlu, Bala Gür, et al.. (2024). miR-770-5p-induced cellular switch to sensitize trastuzumab resistant breast cancer cells targeting HER2/EGFR/IGF1R bidirectional crosstalk. TURKISH JOURNAL OF BIOLOGY. 48(2). 153–162. 2 indexed citations
4.
Gürdal, Hakan, et al.. (2023). miR-216b-5p promotes late apoptosis/necroptosis in trastuzumab-resistant SK-BR-3 cells. TURKISH JOURNAL OF BIOLOGY. 47(3). 199–207. 4 indexed citations
5.
Dedeoğlu, Bala Gür, et al.. (2021). Overexpression of β-Arrestins inhibits proliferation and motility in triple negative breast cancer cells. Scientific Reports. 11(1). 1539–1539. 13 indexed citations
6.
Gürdal, Hakan, et al.. (2021). MiR-25 and KLF4 relationship has early prognostic significance in the development of cervical cancer. Pathology - Research and Practice. 222. 153435–153435. 8 indexed citations
7.
Dedeoğlu, Bala Gür, et al.. (2021). Experimental MicroRNA Targeting Validation. Methods in molecular biology. 2257. 79–90. 4 indexed citations
8.
Gürdal, Hakan, et al.. (2019). Involvement of miR-770-5p in trastuzumab response in HER2 positive breast cancer cells. PLoS ONE. 14(4). e0215894–e0215894. 25 indexed citations
9.
Erden, Didem Dayangaç, et al.. (2018). Do Perineuronal Net Elements Contribute to Pathophysiology of Spinal Muscular Atrophy? In Vitro and Transcriptomics Insights. OMICS A Journal of Integrative Biology. 22(9). 598–606. 6 indexed citations
10.
Dedeoğlu, Bala Gür, Sevil Köse, Arzu Atalay, et al.. (2017). DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia. Leukemia Research. 63. 62–71. 26 indexed citations
11.
Öztürk, Hakime, et al.. (2017). Construction of miRNA-miRNA networks revealing the complexity of miRNA-mediated mechanisms in trastuzumab treated breast cancer cell lines. PLoS ONE. 12(10). e0185558–e0185558. 28 indexed citations
12.
Kaya, Cemil, et al.. (2016). Identification of Polycystic Ovary Syndrome (PCOS) Specific Genes in Cumulus and Mural Granulosa Cells. PLoS ONE. 11(12). e0168875–e0168875. 33 indexed citations
13.
Çoşkunpınar, Ender, et al.. (2015). Determination of effective miRNAs in wound healing in an experimental Rat Model.. Cellular and Molecular Biology. 61(8). 89–96. 5 indexed citations
14.
Dedeoğlu, Bala Gür. (2013). High-Throughput Approaches for MicroRNA Expression Analysis. Methods in molecular biology. 1107. 91–103. 24 indexed citations
15.
Baǧışlar, Sevgi, Haluk Yuzugullu, Şerif Şentürk, et al.. (2010). The Ability to Generate Senescent Progeny as a Mechanism Underlying Breast Cancer Cell Heterogeneity. PLoS ONE. 5(6). e11288–e11288. 19 indexed citations
16.
Dedeoğlu, Bala Gür, et al.. (2009). Identification of Endogenous Reference Genes for qRT-PCR Analysis in Normal Matched Breast Tumor Tissues. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 17(8). 353–365. 46 indexed citations
17.
Dedeoğlu, Bala Gür, Özlen Konu, Serkan Kır, et al.. (2008). A resampling-based meta-analysis for detection of differential gene expression in breast cancer. BMC Cancer. 8(1). 396–396. 15 indexed citations
18.
Yuluğ, Işık G. & Bala Gür Dedeoğlu. (2008). Functional genomics in translational cancer research: focus on breast cancer. Briefings in Functional Genomics and Proteomics. 7(1). 1–7. 3 indexed citations
19.
Bozkurt, Betül, et al.. (2007). Lack of association between the MDM2-SNP309 polymorphism and breast cancer risk.. PubMed. 26(6C). 4975–7. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026